OBJECTIVE To identify published studies quantifying familial prostate cancer risks in
relatives of prostate cancer cases and, by meta‐analysis, obtain more precise estimates of …

Purpose: We review the current epidemiological and genetic knowledge regarding
hereditary prostate cancer, and outline its clinical implications. Materials and Methods …

Purpose To analyze the baseline clinicopathologic characteristics of prostate tumors with
germline BRCA1 and BRCA2 (BRCA1/2) mutations and the prognostic value of those …

Background The worldwide incidence of prostate cancer has been rising rapidly, likely due
to intensified effort in early detection and screening. Intense effort is also directed at novel …

PURPOSE: Hereditary prostate cancer accounts for 5% to 10% of all prostate cancer cases.
We assessed clinical characteristics and survival in patients with hereditary prostate cancer …

Purpose Several earlier studies have assessed survival in prostate cancer based on familial
risk of this disease. As a novel concept, we posit that factors governing survival in prostate …

Background. In prostate cancer, early detection and appropriate treatment remain key
approaches. But given the constantly increasing incidence, prostate cancer …

BACKGROUND Familial prostate cancer (CaP) accounts for 15–20% of all CaP, and
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …

Purpose: There are conflicting reports concerning whether prostate cancer in families with
multiple affected members has different clinical and pathological features than sporadic …

Background To investigate the correlation between family history of prostate cancer (PCa)
and survival (overall and cancer specific) in patients undergoing treatment for PCa. Methods …